Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Danai-Maria Kotzampasi"'
Autor:
Athanasios Panagiotopoulos, Melpomeni Tseliou, Ioannis Karakasiliotis, Danai‐Maria Kotzampasi, Vangelis Daskalakis, Nikolaos Kesesidis, George Notas, Christos Lionis, Marilena Kampa, Stergios Pirintsos, George Sourvinos, Elias Castanas
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been advanced, while natural products have also been tested. Here, we
Externí odkaz:
https://doaj.org/article/788c35684ac9478ca175c2659d613783
Autor:
Athanasios A. Panagiotopoulos, Ioannis Karakasiliotis, Danai-Maria Kotzampasi, Marios Dimitriou, George Sourvinos, Marilena Kampa, Stergios Pirintsos, Elias Castanas, Vangelis Daskalakis
Publikováno v:
Molecules, Vol 26, Iss 19, p 6068 (2021)
3CL-Pro is the SARS-CoV-2 main protease (MPro). It acts as a homodimer to cleave the large polyprotein 1ab transcript into proteins that are necessary for viral growth and replication. 3CL-Pro has been one of the most studied SARS-CoV-2 proteins and
Externí odkaz:
https://doaj.org/article/b7829afdf8234aef9c4bb36d40d73f2d
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 3118-3131 (2024)
The gene PIK3CA, encoding the catalytic subunit p110α of PI3Kα, is the second most frequently mutated gene in cancer, with the highest frequency oncogenic mutants occurring in the C-terminus of the kinase domain. The C-terminus has a dual function
Externí odkaz:
https://doaj.org/article/fb12b9be2c5242a0880c041b2806ad1a
Autor:
Danai Maria Kotzampasi, Kyriaki Premeti, Alexandra Papafotika, Vasiliki Syropoulou, Savvas Christoforidis, Zoe Cournia, George Leondaritis
Publikováno v:
Computational and structural biotechnology journal. 20
The oncogene PI3Kα and the tumor suppressor PTEN represent two antagonistic enzymatic activities that regulate the interconversion of the phosphoinositide lipids PI(4,5)P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04ad34a441db52505fa896dc8c44e84
https://pubmed.ncbi.nlm.nih.gov/36284707
https://pubmed.ncbi.nlm.nih.gov/36284707
Autor:
Marilena Kampa, George Sourvinos, Elias Castanas, Vangelis Daskalakis, Ioannis Karakasiliotis, Danai-Maria Kotzampasi, Athanasios A. Panagiotopoulos, Marios Dimitriou, Stergios Pirintsos
Publikováno v:
Molecules, Vol 26, Iss 6068, p 6068 (2021)
Molecules
Volume 26
Issue 19
Molecules
Volume 26
Issue 19
3CL-Pro is the SARS-CoV-2 main protease (MPro). It acts as a homodimer to cleave the large polyprotein 1ab transcript into proteins that are necessary for viral growth and replication. 3CL-Pro has been one of the most studied SARS-CoV-2 proteins and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9c3d7b896d11e81b8eec8700d1f9ca
https://hdl.handle.net/20.500.14279/24342
https://hdl.handle.net/20.500.14279/24342
Autor:
Nikolaos Kesesidis, George Sourvinos, Marilena Kampa, Christos Lionis, Athanasios A. Panagiotopoulos, Elias Castanas, Vangelis Daskalakis, Melpomeni Tseliou, Danai-Maria Kotzampasi, Stergios Pirintsos, George Notas, Ioannis Karakasiliotis
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been advanced, while natural products have also been tested. Here, we propose t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b4b8753e4e8ac15775e91116ea8a4e3
https://doaj.org/article/788c35684ac9478ca175c2659d613783
https://doaj.org/article/788c35684ac9478ca175c2659d613783